Related Experiment Video
Updated: May 20, 2026

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
Erlin-2 is associated with active γ-secretase in brain and affects amyloid β-peptide production
Yasuhiro Teranishi1, Ji-Yeun Hur, Gucci Jijuan Gu
1Karolinska Institutet Dainippon Sumitomo Pharma Alzheimer Center, KI-Alzheimer Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Novum, Stockholm SE-141 86, Sweden.
Abstract:
The transmembrane protease complex γ-secretase is responsible for the generation of the neurotoxic amyloid β-peptide (Aβ) from its precursor (APP). Aβ has a causative role in Alzheimer disease, and thus, γ-secretase is a therapeutic target. However, since there are more than 70 γ-secretase substrates besides APP, selective inhibition of APP processing is required. Recent data indicates the existence of several γ-secretase associated proteins (GSAPs) that affect the selection and processing of substrates. Here, we use a γ-secretase inhibitor for affinity purification of γ-secretase and associated proteins from microsomes and detergent resistant membranes (DRMs) prepared from rat or human brain. By tandem mass spectrometry we identified a novel brain GSAP; erlin-2. This protein was recently reported to reside in DRMs in the ER. A proximity ligation assay, as well as co-immunoprecipitation, confirmed the association of erlin-2 with γ-secretase. We found that a higher proportion of erlin-2 was associated with γ-secretase in DRMs than in soluble membranes. siRNA experiments indicated that reduced levels of erlin-2 resulted in a decreased Aβ production, whereas the effect on Notch processing was limited. In summary, we have found a novel brain GSAP, erlin-2, that resides in DRMs and affects Aβ production.
Insights
Researchers discovered erlin-2, a novel protein associated with gamma-secretase, which influences amyloid beta-peptide (Aβ) production. This finding is crucial for developing targeted Alzheimer disease therapies by selectively inhibiting Aβ generation.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- The gamma-secretase complex cleaves amyloid precursor protein (APP) to produce neurotoxic amyloid beta-peptide (Aβ), a key factor in Alzheimer disease pathogenesis.
- Selective inhibition of APP processing by gamma-secretase is a therapeutic challenge due to its numerous other substrates.
- Gamma-secretase associated proteins (GSAPs) are implicated in substrate selection and processing.
Purpose of the Study:
- To identify novel GSAPs involved in gamma-secretase substrate processing.
- To investigate the role of identified GSAPs in Aβ production and Alzheimer disease.
- To explore potential therapeutic strategies targeting specific gamma-secretase interactions.
Main Methods:
- Affinity purification of gamma-secretase and associated proteins using a specific inhibitor.
- Tandem mass spectrometry for protein identification.
- Co-immunoprecipitation and proximity ligation assays to confirm protein interactions.
- siRNA experiments to assess the functional impact of erlin-2 on Aβ and Notch processing.
Main Results:
- A novel brain GSAP, erlin-2, was identified and found to associate with gamma-secretase.
- Erlin-2 predominantly resides in detergent-resistant membranes (DRMs) and its association with gamma-secretase is higher in DRMs.
- Reduced erlin-2 levels led to decreased Aβ production with minimal impact on Notch processing.
Conclusions:
- Erlin-2 is a novel brain-specific GSAP that interacts with gamma-secretase within DRMs.
- Erlin-2 plays a role in modulating Aβ production, suggesting it as a potential therapeutic target for Alzheimer disease.
- The findings highlight the importance of GSAPs in understanding and targeting gamma-secretase activity.
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Protein Modifications in the RER
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
The Unfolded Protein Response
Alzheimer Disease ll: Pathophysiology
Protein Folding Quality Check in the RER
Role of ER in the Secretory Pathway
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...

